Health ❯ Healthcare ❯ Biotechnology
COVID-19 mRNA Vaccines mRNA Technology COVID-19 Vaccines COVID-19 Vaccine mRNA Therapeutics
The move shrinks its staff to under 5,000 by year-end to cut $1.5 billion in annual expenses by 2027.
